(Q38131790)

29 August 2017

title

Novel biomarkers for heart failure (English)

1 reference

29 August 2017

0 references

0 references

Navaid Iqbal

1

1 reference

29 August 2017

Khwaja Sami Alim

2

1 reference

29 August 2017

Hermineh Aramin

3

1 reference

29 August 2017

Fatima Iqbal

4

1 reference

29 August 2017

Erik Green

5

1 reference

29 August 2017

Erin Higginbotham

6

1 reference

29 August 2017

Alan S Maisel

7

1 reference

29 August 2017

publication date

28 August 2013

1 reference

Expert Review of Cardiovascular Therapy

29 August 2017

published in

1 reference

29 August 2017

volume

11

1 reference

29 August 2017

issue

9

1 reference

29 August 2017

page(s)

1155-1169

1 reference

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Characterization of immunoreactive brain natriuretic peptide in human cardiac atrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Concentrations and molecular forms of human brain natriuretic peptide in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Impact of obesity on plasma natriuretic peptide levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

The paradox of low BNP levels in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

The differential diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide level

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Elevated B-type natriuretic peptide levels after anthracycline administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Atrial natriuretic peptide prohormone gene expression: hormones and diseases that upregulate its expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Cardiac hormones as diagnostic tools in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Release of cardiac troponin in acute coronary syndromes: ischemia or necrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Predictive value of the high-sensitivity troponin T assay and the simplified Pulmonary Embolism Severity Index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Prevalence, determinants, and clinical significance of cardiac troponin-I elevation in individuals admitted for a hypertensive emergency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Elevated urinary neutrophil gelatinase-associated lipocalcin after acute heart failure treatment is associated with worsening renal function and adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Relation of systemic and urinary neutrophil gelatinase-associated lipocalin levels to different aspects of impaired renal function in patients with acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Procalcitonin as a marker of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

The impact of pre-existing heart failure on pneumonia prognosis: population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

The association between pneumococcal pneumonia and acute cardiac events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Circulating procalcitonin and cleavage products in septicaemia compared with medullary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Procalcitonin: Uses in the Clinical Laboratory for the Diagnosis of Sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the EPIC-Norfolk prospective population study 1993-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Inflammatory markers and onset of cardiovascular events: results from the Health ABC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Interleukin 6: a message from the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

C-reactive protein as a predictor of improvement and readmission in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

C-reactive protein in acute myocardial infarction: association with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Co-peptin: Role as a novel biomarker in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Vasopressin antagonism in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Short-term mortality risk in emergency department acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Growth-differentiation factor-15 in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Risk stratification of chronic heart failure patients by multiple biomarkers: implications of BNP, H-FABP, and PTX3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Combination of conventional biomarkers for risk stratification in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Independent and additive prognostic ability of serum carboxy-terminal telopeptide of collagen type-I in heart failure patients: a multi-marker approach with high-negative predictive value to rule out long-term adverse events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Prediction of long-term survival in chronic heart failure by multiple biomarker assessment: a 15-year prospective follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of dyspneic ED patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.832476

10.1586/14779072.2013.832476

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference